191 related articles for article (PubMed ID: 28651624)
1. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China.
Fang H; Lin X; Zhang J; Hong Z; Sugiyama K; Nozaki T; Sameshima T; Kobayashi S; Namba H; Asakawa T
BMC Pharmacol Toxicol; 2017 Jun; 18(1):49. PubMed ID: 28651624
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia.
Nadew SS; Beyene KG; Beza SW
PLoS One; 2020; 15(1):e0227712. PubMed ID: 31961883
[TBL] [Abstract][Full Text] [Related]
3. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
5. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
Herdeiro MT; Ribeiro-Vaz I; Ferreira M; Polónia J; Falcão A; Figueiras A
Drug Saf; 2012 Aug; 35(8):655-65. PubMed ID: 22788235
[TBL] [Abstract][Full Text] [Related]
6. Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital.
Goldstein LH; Berlin M; Saliba W; Elias M; Berkovitch M
J Clin Pharmacol; 2013 Nov; 53(11):1220-5. PubMed ID: 23852627
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
[TBL] [Abstract][Full Text] [Related]
8. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Matos C; van Hunsel F; Joaquim J
Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
[TBL] [Abstract][Full Text] [Related]
9. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.
Pedrós C; Vallano A; Cereza G; Mendoza-Aran G; Agustí A; Aguilera C; Danés I; Vidal X; Arnau JM
Drug Saf; 2009; 32(1):77-83. PubMed ID: 19132807
[TBL] [Abstract][Full Text] [Related]
10. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.
Lopez-Gonzalez E; Herdeiro MT; Piñeiro-Lamas M; Figueiras A;
Drug Saf; 2015 Feb; 38(2):189-96. PubMed ID: 25537234
[TBL] [Abstract][Full Text] [Related]
11. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
12. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
13. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
14. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
15. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
[TBL] [Abstract][Full Text] [Related]
16. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
[TBL] [Abstract][Full Text] [Related]
17. A time series analysis of the effects of financial incentives and mandatory clinical applications as interventions to improve spontaneous adverse drug reaction reporting by hospital medical staff in China.
Chang F; Xi Y; Zhao J; Zhang X; Lu Y
J Eval Clin Pract; 2017 Dec; 23(6):1316-1321. PubMed ID: 28675578
[TBL] [Abstract][Full Text] [Related]
18. Improving the data quality of spontaneous ADR reports: a practical example from Malta.
Zuccarelli M; Micallef B; Butler D; Serracino-Inglott A; Borg JJ
Expert Opin Drug Saf; 2022 Feb; 21(2):253-268. PubMed ID: 34649475
[TBL] [Abstract][Full Text] [Related]
19. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
Mulchandani R; Kakkar AK
Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
[TBL] [Abstract][Full Text] [Related]
20. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals.
Pérez García M; Figueras A
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1295-302. PubMed ID: 21793098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
